A trivial role of STAT4 variant in chronic hepatitis B induced hepatocellular carcinoma

Infection, Genetics and Evolution

Volumn 18, Issue , 2013, Pages 257-261

  Clark, Adam ^a,b   Gerlach, Franziska ^a   Tong, Hoang van ^a   Hoan, Nghiem Xuan ^c   Song, Le H ^c   Toan, Nguyen L ^d   Bock, C Thomas ^e   Kremsner, Peter G ^a   Velavan, Thirumalaisamy P ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c Tran Hung Dao Hospital   (Viet Nam)

^d VIETNAM MILITARY MEDICAL UNIVERSITY   (Viet Nam)

^e ROBERT KOCH INSTITUTE   (Germany)

Author keywords

CHB induced HCC; HBV infection; HLA DQ locus; STAT4

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA FETOPROTEIN; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; STAT4 PROTEIN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CANCER SUSCEPTIBILITY; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; STAT4 GENE; VIET NAM; VIRUS CARRIER; VIRUS LOAD;

CHB INDUCED HCC; HBV INFECTION; HLA-DQ LOCUS; STAT4;

ADOLESCENT; ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; DISEASE PROGRESSION; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS B, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; STAT4 TRANSCRIPTION FACTOR; YOUNG ADULT;

HEPATITIS B VIRUS;

EID: 84879596104     PISSN: 15671348     EISSN: 15677257     Source Type: Journal    
DOI: 10.1016/j.meegid.2013.05.025     Document Type: Article

References (22)

1. Al-Qahtani A., Al-Anazi M., Viswan N.A., Khalaf N., Abdo A.A., Sanai F.M., Al-Ashgar H., Al-Ahdal M. Role of single nucleotide polymorphisms of KIF1B gene in HBV-associated viral hepatitis. PLoS One 2012, 7:e45128.
2. Di Bisceglie A.M. Hepatitis B and hepatocellular carcinoma. Hepatology 2009, 49:S56-S60.
3. Guo X., Zhang Y., Li J., Ma J., Wei Z., Tan W., O'Brien S.J. Strong influence of human leukocyte antigen (HLA)-DP gene variants on development of persistent chronic hepatitis B virus carriers in the han Chinese population. Hepatology 2011, 53:422-428.
4. Tong H.V., Toan N.L., Song L.H., Bock C.-T., Kremsner P.G., Velavan T.P. Hepatitis B virus-induced hepatocellular carcinoma: functional roles of MICA variants 2013, J. Viral Hepat.
5. Hirschfield G.M., Liu X., Xu C., Lu Y., Xie G., Lu Y., Gu X., Walker E.J., Jing K., Juran B.D., Mason A.L., Myers R.P., Peltekian K.M., Ghent C.N., Coltescu C., Atkinson E.J., Heathcote E.J., Lazaridis K.N., Amos C.I., Siminovitch K.A. Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variants. N. Engl. J. Med. 2009, 360:2544-2555.
6. Hoang T.V., Toan N.L., Song I.H., Ouf E.A., Bock C.T., Kremsner P.G., Kun J.F., Velavan T.P. Ficolin-2 levels and FCN2 haplotypes influence hepatitis B infection outcome in Vietnamese patients. PLoS One 2011, 6:e28113.
7. Horras C.J., Lamb C.L., Mitchell K.A. Regulation of hepatocyte fate by interferon-gamma. Cytokine Growth Factor Rev. 2011, 22:35-43.
8. Hu L., Zhai X., Liu J., Chu M., Pan S., Jiang J., Zhang Y., Wang H., Chen J., Shen H., Hu Z. Genetic variants in human leukocyte antigen/DP-DQ influence both hepatitis B virus clearance and hepatocellular carcinoma development. Hepatology 2012, 55:1426-1431.
9. Jiang D.K., Sun J., Cao G., Liu Y., Lin D., Gao Y.Z., Ren W.H., Long X.D., Zhang H., Ma X.P., Wang Z., Jiang W., Chen T.Y., Gao Y., Sun L.D., Long J.R., Huang H.X., Wang D., Yu H., Zhang P., Tang L.S., Peng B., Cai H., Liu T.T., Zhou P., Liu F., Lin X., Tao S., Wan B., Sai-Yin H.X., Qin L.X., Yin J., Liu L., Wu C., Pei Y., Zhou Y.F., Zhai Y., Lu P.X., Tan A., Zuo X.B., Fan J., Chang J., Gu X., Wang N.J., Li Y., Liu Y.K., Zhai K., Zhang H., Hu Z., Liu J., Yi Q., Xiang Y., Shi R., Ding Q., Zheng W., Shu X.O., Mo Z., Shugart Y.Y., Zhang X.J., Zhou G., Shen H., Zheng S.L., Xu J., Yu L. Genetic variants in STAT4 and HLA-DQ genes confer risk of hepatitis B virus-related hepatocellular carcinoma. Nat. Genet. 2013, 45:72-75.
10. Kamatani Y., Wattanapokayakit S., Ochi H., Kawaguchi T., Takahashi A., Hosono N., Kubo M., Tsunoda T., Kamatani N., Kumada H., Puseenam A., Sura T., Daigo Y., Chayama K., Chantratita W., Nakamura Y., Matsuda K. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nat. Genet. 2009, 41:591-595.
11. Kariuki S.N., Kirou K.A., MacDermott E.J., Barillas-Arias L., Crow M.K., Niewold T.B. Cutting edge: autoimmune disease risk variant of STAT4 confers increased sensitivity to IFN-alpha in lupus patients in vivo. J. Immunol. 2009, 182:34-38.
12. Klein J., Sato A. The HLA system. First of two parts. N. Engl. J. Med. 2000, 343:702-709.
13. Li S., Qian J., Yang Y., Zhao W., Dai J., Bei J.X., Foo J.N., McLaren P.J., Li Z., Yang J., Shen F., Liu L., Yang J., Li S., Pan S., Wang Y., Li W., Zhai X., Zhou B., Shi L., Chen X., Chu M., Yan Y., Wang J., Cheng S., Shen J., Jia W., Liu J., Yang J., Wen Z., Li A., Zhang Y., Zhang G., Luo X., Qin H., Chen M., Wang H., Jin L., Lin D., Shen H., He L., De Bakker P.I., Wang H., Zeng Y.X., Wu M., Hu Z., Shi Y., Liu J., Zhou W. GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS. Genet. 2012, 8:e1002791.
14. Mbarek H., Ochi H., Urabe Y., Kumar V., Kubo M., Hosono N., Takahashi A., Kamatani Y., Miki D., Abe H., Tsunoda T., Kamatani N., Chayama K., Nakamura Y., Matsuda K. A genome-wide association study of chronic hepatitis B identified novel risk locus in a Japanese population. Hum. Mol. Genet. 2011, 20:3884-3892.
15. Mells G.F., Floyd J.A., Morley K.I., Cordell H.J., Franklin C.S., Shin S.Y., Heneghan M.A., Neuberger J.M., Donaldson P.T., Day D.B., Ducker S.J., Muriithi A.W., Wheater E.F., Hammond C.J., Dawwas M.F., Jones D.E., Peltonen L., Alexander G.J., Sandford R.N., Anderson C.A. Genome-wide association study identifies 12 new susceptibility loci for primary biliary cirrhosis. Nat. Genet. 2011, 43:329-332.
16. O'Shea J.J., Holland S.M., Staudt L.M. JAKs and STATs in immunity, immunodeficiency, and cancer. N. Engl. J. Med. 2013, 368:161-170.
17. Ojurongbe O., Ouf E.A., Van T.H., Toan N.L., Song I.H., Luz P.R., Messias-Reason I.J., Nurjadi D., Zanger P., Kun J.F., Kremsner P.G., Velavan T.P., Toan N.L. Reliable and rapid characterization of functional FCN2 gene variants reveals diverse geographical patterns. BMC Med. Genet. 2012, 13:37.
18. Remmers E.F., Plenge R.M., Lee A.T., Graham R.R., Hom G., Behrens T.W., de Bakker P.I., Le J.M., Lee H.S., Batliwalla F., Li W., Masters S.L., Booty M.G., Carulli J.P., Padyukov L., Alfredsson L., Klareskog L., Chen W.V., Amos C.I., Criswell L.A., Seldin M.F., Kastner D.L., Gregersen P.K. STAT4 and the risk of rheumatoid arthritis and systemic lupus erythematosus. N. Engl. J. Med. 2007, 357:977-986.
19. Sawai H., Nishida N., Mbarek H., Matsuda K., Mawatari Y., Yamaoka M., Hige S., Kang J.H., Abe K., Mochida S., Watanabe M., Kurosaki M., Asahina Y., Izumi N., Honda M., Kaneko S., Tanaka E., Matsuura K., Itoh Y., Mita E., Korenaga M., Hino K., Murawaki Y., Hiasa Y., Ide T., Ito K., Sugiyama M., Ahn S.H., Han K.H., Park J.Y., Yuen M.F., Nakamura Y., Tanaka Y., Mizokami M., Tokunaga K. No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations. BMC Med. Genet. 2012, 13:47.
20. Wang Z.C., Gao Q., Shi J.Y., Yang L.X., Zhou J., Wang X.Y., Shi Y.H., Ke A.W., Shi G.M., Ding Z.B., Dai Z., Qiu S.J., Fan J. Genetic polymorphism of the kinesin-like protein KIF1B gene and the risk of hepatocellular carcinoma. PLoS One 2013, 8:e62571.
21. Zhang H., Zhai Y., Hu Z., Wu C., Qian J., Jia W., Ma F., Huang W., Yu L., Yue W., Wang Z., Li P., Zhang Y., Liang R., Wei Z., Cui Y., Xie W., Cai M., Yu X., Yuan Y., Xia X., Zhang X., Yang H., Qiu W., Yang J., Gong F., Chen M., Shen H., Lin D., Zeng Y.X., He F., Zhou G. Genome-wide association study identifies 1p36.22 as a new susceptibility locus for hepatocellular carcinoma in chronic hepatitis B virus carriers. Nat. Genet. 2010, 42:755-758.
22. Zhong R., Tian Y., Liu L., Qiu Q., Wang Y., Rui R., Yang B.F., Duan S.Y., Shi J.X., Miao X.P., Wang L., Li H. HBV-related hepatocellular carcinoma susceptibility gene KIF1B is not associated with development of chronic hepatitis B. PLoS One 2012, 7:e28839.